Lorraine Leblond
Impact in
- Hematology top 5%
- Blood Coagulation and Thrombosis Mechanisms
- Genetics top 10%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
Papers in
-
- Chemical Synthesis and Analysis 5
- Peroxisome Proliferator-Activated Receptors 3
-
- Blood Coagulation and Thrombosis Mechanisms 5
- Co-authors
- Yves L. Marcel (3 shared papers)Morley D. Hollenberg (2 shared papers)Atsufumi Kawabata (1 shared paper)Mahmoud Saifeddine (1 shared paper)Bahjat Al‐Ani (1 shared paper)Henriette Gourdeau (6 shared papers)Bettina A. Hamelin (4 shared papers)Kelly Dong (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of Biological Chemistry (3 papers)Thrombosis Research (3 papers)Molecular Cancer Therapeutics (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- CanadaUnited StatesSouth Africa
In The Last Decade
Lorraine Leblond
21 papers receiving 786 citations
Peers
Comparison fields: 5 of 82
- Hematology 237
- Genetics 143
- Organic Chemistry 321
- Immunology and Allergy 58
- Cancer Research 122
Countries citing papers authored by Lorraine Leblond
This map shows the geographic impact of Lorraine Leblond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorraine Leblond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorraine Leblond more than expected).
Fields of papers citing papers by Lorraine Leblond
This network shows the impact of papers produced by Lorraine Leblond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorraine Leblond. The network helps show where Lorraine Leblond may publish in the future.
Co-authors
The 25 scholars most cited alongside Lorraine Leblond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 262 | |
| 2 | 1999 | 189 | |
| 3 | 2003 | 63 | |
| 4 | 1991 | 54 | |
| 5 | 1989 | 36 | |
| 6 | 1993 | 36 | |
| 7 | 1998 | 35 | |
| 8 | 2007 | 25 | |
| 9 | 2001 | 23 | |
| 10 | 2002 | 17 | |
| 11 | 2004 | 16 | |
| 12 | 1998 | 14 | |
| 13 | 1996 | 14 | |
| 14 | 2001 | 14 | |
| 15 | BCH-1868 [(-)-2-R-dihydroxyphosphinoyl-5-(S)-(guanin-9'-yl-methyl) tetrahydrofuran]: a cyclic nucleoside phosphonate with antitumor activity. | 2002 | 11 |
| 16 | 2003 | 10 | |
| 17 | 2000 | 7 | |
| 18 | 1999 | 3 | |
| 19 | 2000 | 2 | |
| 20 | 1988 | 2 |
About Lorraine Leblond
Lorraine Leblond is a scholar working on Molecular Biology, Hematology, Oncology, Organic Chemistry and Surgery, having authored 21 papers that have together received 835 indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (5 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers), Peptidase Inhibition and Analysis (4 papers), Cell Adhesion Molecules Research (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Heparin-Induced Thrombocytopenia and Thrombosis (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). The work is most often cited by research in Hematology (237 citations), Genetics (143 citations), Organic Chemistry (321 citations), Immunology and Allergy (58 citations) and Cancer Research (122 citations). Lorraine Leblond has collaborated with scholars based in Canada, United States and South Africa. Frequent co-authors include Yves L. Marcel, Morley D. Hollenberg, Atsufumi Kawabata, Mahmoud Saifeddine, Bahjat Al‐Ani, Henriette Gourdeau, Bettina A. Hamelin, Kelly Dong, Shailaja Kasibhatla and Denis Labrecque. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Biological Chemistry, Thrombosis Research, Molecular Cancer Therapeutics and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.